Literature DB >> 1171754

Behaviour of doxycycline in the tissues.

P Blanchard, M Rudhardt, J Fabre.   

Abstract

Little is known about the behaviour of antibiotics in the tissues. To investigate this problem, rats were sacrificed in groups of six, 1, 2, 4, 6, 8, 12 and 18 h after an intraperitoneal injection of 10 mg doxycycline/kg body weight. The antibiotic levels were determined in the nine major organs and in the serum by a microbiological method. One hour after injection, the doxycycline concentrations in all the tissues were already higher than the serum concentrations. After 4 h, the concentration exceeded 2.5 mug/ml in the lungs, muscles, testes and heart, and were much greater in the excretory organs: 11.4 +/- 4.1 mug/ml in the liver, 10.2 +/- 1.6 in the renal medulla and 27.8 +/- 7.0 in the renal cortex. Throughout the experiment, the lung and muscle concentrations were about double the serum concentrations, and this occurred with great regularity. Doxycycline is thus capable of penetrating extremely rapidly and intensely into tissues, while still retaining a great degree of freedom of movement between plasma and tissues.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171754     DOI: 10.1159/000221886

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

1.  A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection.

Authors:  Rebekah K Franklin; Sarah A Marcus; Adel M Talaat; Butch K KuKanich; Ruth Sullivan; Lisa A Krugner-Higby; Timothy D Heath
Journal:  Drug Metab Dispos       Date:  2015-06-01       Impact factor: 3.922

Review 2.  Clinical pharmacokinetics of doxycycline and minocycline.

Authors:  S Saivin; G Houin
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

3.  Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects.

Authors:  P G Welling; P A Koch; C C Lau; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  Reducing Aspergillus fumigatus Virulence through Targeted Dysregulation of the Conidiation Pathway.

Authors:  James I P Stewart; Vinicius M Fava; Joshua D Kerkaert; Adithya S Subramanian; Fabrice N Gravelat; Melanie Lehoux; P Lynne Howell; Robert A Cramer; Donald C Sheppard
Journal:  mBio       Date:  2020-02-04       Impact factor: 7.867

5.  Confounding factors from inducible systems for spatiotemporal gene expression regulation.

Authors:  Rob C I Wüst; Riekelt H Houtkooper; Johan Auwerx
Journal:  J Cell Biol       Date:  2020-07-06       Impact factor: 10.539

6.  Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.

Authors:  Sarah Aherfi; Bruno Pradines; Christian Devaux; Stéphane Honore; Philippe Colson; Bernard La Scola; Didier Raoult
Journal:  Future Microbiol       Date:  2021-11-10       Impact factor: 3.165

7.  Tissue Distribution of Doxycycline in Animal Models of Tuberculosis.

Authors:  Martin Gengenbacher; Matthew D Zimmerman; Jansy P Sarathy; Firat Kaya; Han Wang; Marizel Mina; Claire Carter; Md Amir Hossen; Hongwei Su; Carolina Trujillo; Sabine Ehrt; Dirk Schnappinger; Véronique Dartois
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

8.  In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2.

Authors:  Mathieu Gendrot; Julien Andreani; Priscilla Jardot; Sébastien Hutter; Océane Delandre; Manon Boxberger; Joel Mosnier; Marion Le Bideau; Isabelle Duflot; Isabelle Fonta; Clara Rolland; Hervé Bogreau; Bernard La Scola; Bruno Pradines
Journal:  Molecules       Date:  2020-10-31       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.